🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.

Some professionals stated the demand for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Response and Content Removal

Based on TikTok, the service has removed violative content and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

After moments of joining one community, a vendor shared contact information, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, health issues or past usage.

Product Details and Costs

Within these groups, posts display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to potentially serious medical dangers”.